LANZA, Francesco
LANZA, Francesco
Dipartimento di Medicina Traslazionale e per la Romagna
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach
2017 Lanza, F.; Saraceni, F.; Pezzi, A.; Martino, M.; Bosi, A.; Cascavilla, N.; Musto, P.; Zuffa, E.; Tani, M.; Cellini, C.; Laszlo, D.; Bonifazi, F.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi
2018 Olivieri, J.; Mosna, F.; Pelosini, M.; Fama, A.; Rattotti, S.; Giannoccaro, M.; Carli, G.; Tisi, M. C.; Ferrero, S.; Sgherza, N.; Mazzone, A. M.; Marino, D.; Calimeri, T.; Loseto, G.; Saraceni, F.; Tomei, G.; Sica, S.; Perali, G.; Codeluppi, K.; Billio, A.; Olivieri, A.; Orciuolo, E.; Matera, R.; Stefani, P. M.; Borghero, C.; Ghione, P.; Cascavilla, N.; Lanza, F.; Chiusolo, P.; Finotto, S.; Federici, I.; Gherlinzoni, F.; Centurioni, R.; Fanin, R.; Zaja, F.
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs
2009 Campioni, D; Rizzo, R.; Stignani, M.; Melchiorri, L.; Ferrari, L.; Moretti, S.; Russo, A.; Bagnara, Gp.; Alviano, F.; Lanzoni, G.; Cuneo, A.; Baricordi, Or.; Lanza, F.
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells
2008 Rizzo, R.; Campioni, D.; Stignani, M.; Bagnara, Gp.; Bonsi, L.; Alviano, F.; Lanzoni, G.; Moretti, S.; Cuneo, A.; Lanza, F.; Baricordi, O.
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers
2008 Lanza, F; Rizzo, R; Campioni, D; Stignani, A; Melchiorri, L; Bagnara, Gp; Lanzoni, G; Moretti, S; Baricordi, O; Cuneo, A
A revised model of platelet aggregation
file con accesso da definire2000 Kulkarni, S; Dopheide, Sm; Yap, Cl; Ravanat, C; Freund, M; Mangin, P; Heel, Ka; Street, A; Harper, Is; Lanza, F; Jackson, Sp
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential
file con accesso da definire2011 Rizzo, Roberta; Lanzoni, G.; Stignani, Marina; Campioni, Diana; Alviano, F.; Ricci, F.; Tazzari, P. L.; Melchiorri, L.; Zaccaria Scalinci, S.; Cuneo, Antonio; Bonsi, L.; Lanza, Francesco; Bagnara, G. P.; Baricordi, Olavio
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders
2007 Lanza, F.; Campioni, D.; Moretti, S.; Ferrari, L.; Rizzo, R.; Baricordi, O.; Cuneo, A.
Abnormal epression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukaemia
file con accesso da definire1993 Lanza, F; Sucai, Bi; Castoldi, G. L.; Goldman, Jm
Absence of HTLV-1 in myelodysplastic syndromes in an area non endemic for HTLV-1 infection.
file con accesso da definire1999 Morselli, M.; Luppi, M.; Barozzi, P.; Dominici, M.; Campioni, Diana; Lanza, Francesco; Cagassi, K.; Pietramaggiori, A.; Marasca, R.; Longo, G.; Emilia, G.; Torelli, G.
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have a common risk factors ?
file con accesso da definire2000 Pagano, L; Pulsoni, A; Tosti, Me; Mele, L; Del Poeta, G; Lanza, F; Masini, L; Equitani, F; Leone, G; Mandeli, F
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry
2014 Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ballestrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database
2017 Necchi, A.; Lo Vullo, S.; Rosti, G.; Badoglio, M.; Giannatempo, P.; Raggi, D.; Secondino, S.; Mariani, L.; Lanza, F.; Pedrazzoli, P.
Adverse haematological effects of ticlopidine. A report of four cases
file con accesso da definire2000 Gallerani, M.; Manfredini, Roberto; Donega', F.; Lanza, Francesco; DA BUSTI, M.; Vigna, Giovanni Battista; Fellin, Renato
AIDS associated non Hodgkin’s lymphoma in Italy: intraveneous drug users versus homosexual men
file con accesso da definire1990 Lanza, F
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation
2017 Gratwohl, A.; Sureda, A.; Cornelissen, J.; Apperley, J.; Dreger, P.; Duarte, R.; Greinix, H. T.; Mc Grath, E.; Kroeger, N.; Lanza, F.; Nagler, A.; Snowden, J. A.; Niederwieser, D.; Brand, R.
Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases
file con accesso da definire1988 Cuneo, A; Lanza, F; Spanedda, R; Tomasi, P; Ferrari, L; Castoldi, Gl
Ammonium Chloride Lysing Solution. Support protocol for CD34 cell analysis
file con accesso da definire2003 Keeney, M; Brown, W; Gratama, J; Papa, S; Lanza, F; Sutherland, R
An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy
2020 Lanza, F; Seghatchian, J
An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man
2016 Lanza, F.; Lazzari, M. C.; Brambilla, P.; Di Martino, G.; Spedini, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach | 2017 | Lanza, F.; Saraceni, F.; Pezzi, A.; Martino, M.; Bosi, A.; Cascavilla, N.; Musto, P.; Zuffa, E.; ...Tani, M.; Cellini, C.; Laszlo, D.; Bonifazi, F. | |
| A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi | 2018 | Olivieri, J.; Mosna, F.; Pelosini, M.; Fama, A.; Rattotti, S.; Giannoccaro, M.; Carli, G.; Tisi, ...M. C.; Ferrero, S.; Sgherza, N.; Mazzone, A. M.; Marino, D.; Calimeri, T.; Loseto, G.; Saraceni, F.; Tomei, G.; Sica, S.; Perali, G.; Codeluppi, K.; Billio, A.; Olivieri, A.; Orciuolo, E.; Matera, R.; Stefani, P. M.; Borghero, C.; Ghione, P.; Cascavilla, N.; Lanza, F.; Chiusolo, P.; Finotto, S.; Federici, I.; Gherlinzoni, F.; Centurioni, R.; Fanin, R.; Zaja, F. | |
| A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs | 2009 | Campioni, D; Rizzo, R.; Stignani, M.; Melchiorri, L.; Ferrari, L.; Moretti, S.; Russo, A.; Bagnar...a, Gp.; Alviano, F.; Lanzoni, G.; Cuneo, A.; Baricordi, Or.; Lanza, F. | |
| A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells | 2008 | Rizzo, R.; Campioni, D.; Stignani, M.; Bagnara, Gp.; Bonsi, L.; Alviano, F.; Lanzoni, G.; Moretti..., S.; Cuneo, A.; Lanza, F.; Baricordi, O. | |
| A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers | 2008 | Lanza, F; Rizzo, R; Campioni, D; Stignani, A; Melchiorri, L; Bagnara, Gp; Lanzoni, G; Moretti, S;... Baricordi, O; Cuneo, A | |
| A revised model of platelet aggregation | 2000 | Kulkarni, S; Dopheide, Sm; Yap, Cl; Ravanat, C; Freund, M; Mangin, P; Heel, Ka; Street, A; Harper..., Is; Lanza, F; Jackson, Sp | file con accesso da definire |
| A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential | 2011 | Rizzo, Roberta; Lanzoni, G.; Stignani, Marina; Campioni, Diana; Alviano, F.; Ricci, F.; Tazzari, ...P. L.; Melchiorri, L.; Zaccaria Scalinci, S.; Cuneo, Antonio; Bonsi, L.; Lanza, Francesco; Bagnara, G. P.; Baricordi, Olavio | file con accesso da definire |
| Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders | 2007 | Lanza, F.; Campioni, D.; Moretti, S.; Ferrari, L.; Rizzo, R.; Baricordi, O.; Cuneo, A. | |
| Abnormal epression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukaemia | 1993 | Lanza, F; Sucai, Bi; Castoldi, G. L.; Goldman, Jm | file con accesso da definire |
| Absence of HTLV-1 in myelodysplastic syndromes in an area non endemic for HTLV-1 infection. | 1999 | Morselli, M.; Luppi, M.; Barozzi, P.; Dominici, M.; Campioni, Diana; Lanza, Francesco; Cagassi, K....; Pietramaggiori, A.; Marasca, R.; Longo, G.; Emilia, G.; Torelli, G. | file con accesso da definire |
| Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have a common risk factors ? | 2000 | Pagano, L; Pulsoni, A; Tosti, Me; Mele, L; Del Poeta, G; Lanza, F; Masini, L; Equitani, F; Leone,... G; Mandeli, F | file con accesso da definire |
| Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry | 2014 | Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ball...estrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare | |
| Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database | 2017 | Necchi, A.; Lo Vullo, S.; Rosti, G.; Badoglio, M.; Giannatempo, P.; Raggi, D.; Secondino, S.; Mar...iani, L.; Lanza, F.; Pedrazzoli, P. | |
| Adverse haematological effects of ticlopidine. A report of four cases | 2000 | Gallerani, M.; Manfredini, Roberto; Donega', F.; Lanza, Francesco; DA BUSTI, M.; Vigna, Giovanni ...Battista; Fellin, Renato | file con accesso da definire |
| AIDS associated non Hodgkin’s lymphoma in Italy: intraveneous drug users versus homosexual men | 1990 | Lanza, F | file con accesso da definire |
| Alloreactivity: the Janus-face of hematopoietic stem cell transplantation | 2017 | Gratwohl, A.; Sureda, A.; Cornelissen, J.; Apperley, J.; Dreger, P.; Duarte, R.; Greinix, H. T.; ...Mc Grath, E.; Kroeger, N.; Lanza, F.; Nagler, A.; Snowden, J. A.; Niederwieser, D.; Brand, R. | |
| Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases | 1988 | Cuneo, A; Lanza, F; Spanedda, R; Tomasi, P; Ferrari, L; Castoldi, Gl | file con accesso da definire |
| Ammonium Chloride Lysing Solution. Support protocol for CD34 cell analysis | 2003 | Keeney, M; Brown, W; Gratama, J; Papa, S; Lanza, F; Sutherland, R | file con accesso da definire |
| An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy | 2020 | Lanza, F; Seghatchian, J | |
| An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man | 2016 | Lanza, F.; Lazzari, M. C.; Brambilla, P.; Di Martino, G.; Spedini, P. |